Here are some dirt-cheap MedTech value stocks - DYNT, INGN, AVNS - which are expected to provide long-term gains.

Masimo (MASI) W1 Watch With Hi to Improve Patient Outcome

05:06pm, Thursday, 08'th Dec 2022 Zacks Investment Research
Masimo's (MASI) full-market release of the Hi for the Masimo W1 watch is likely to significantly improve RPM.
Masimo's (MASI) full-market release of the Hi for the Masimo W1 watch is likely to significantly improve RPM.

Masimo (MASI) Announces Positive Study Results on PBM by SpHb

05:33pm, Monday, 05'th Dec 2022 Zacks Investment Research
Masimo's (MASI) SpHb is likely to enhance transfusion management and post-operative patient outcomes on patients.
Masimo's (MASI) SpHb is likely to enhance transfusion management and post-operative patient outcomes on patients.

Expert Ratings for Masimo

01:03pm, Monday, 05'th Dec 2022 Benzinga
Analysts have provided the following ratings for Masimo (NASDAQ:MASI) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 1 2 0 0 Last 30D

7 Analysts Have This to Say About Masimo

12:02pm, Monday, 05'th Dec 2022 Benzinga
Analysts have provided the following ratings for Masimo (NASDAQ:MASI) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 1 2 0 0 Last 30D
The CEO of Masimo Corporation ( MASI , Financial) recently bought a significant number of his company's shares. According to the GuruFocus CEO Buys screener, Joe Kiani bought 39,778 shares of his comp
Although US stocks closed higher on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stoc

Masimo (MASI) Q3 Earnings Top Estimates, 2022 View Revised

03:38pm, Wednesday, 09'th Nov 2022 Zacks Investment Research
Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q3 sales.

6 Analysts Have This to Say About Masimo

02:34pm, Wednesday, 09'th Nov 2022 Benzinga
Within the last quarter, Masimo (NASDAQ:MASI) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 2 0 0 Last 30D 0 0
Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q3 sales.

Masimo (MASI) Q3 Earnings and Revenues Surpass Estimates

10:55pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
Masimo (MASI) delivered earnings and revenue surprises of 8.70% and 2.87%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Masimo Corporation (NASDAQ:MASI ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Eli Kammerman – Vice President-Business Development and Investor Relations Joe Kia
Masimo (MASI) delivered earnings and revenue surprises of 8.70% and 2.87%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE